Prevalence of anticipatory nausea and vomiting in breast cancer patients undergoing highly emetogenic chemotherapy.

Rafaela de Brito Alves Camilla Vieira de Rebouças Alayne Magalhães Trindade Domingues Yamada Felipe Cavalcanti Carneiro da Silva

Published in: Revista da Associacao Medica Brasileira (1992) (2024)

The prevalence of anticipatory nausea is still high in the era of neurokinin-1 antagonists, and failure of antiemetic control in C1 remains the main risk factor. All efforts should be made to control chemotherapy-induced nausea or nausea and vomiting on C1 to avoid anticipatory nausea.

Keyphrases

chemotherapy induced
risk factors
patients undergoing
squamous cell carcinoma
radiation therapy
rectal cancer